Distal Entry Tear

1

Review clinical trials related to Distal Entry Tear. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Guo&Amp;'s Distal Entry Tear Repair With WeFlow-EndoPatch System (Gallant Study)

A Multicenter, Randomized Controlled Study About the Safety and Efficacy of WeFlow-EndoPatch Aortic Endovascular Patch System manufactured by EndoNom Medtech (Hangzhou) Co., Ltd. for Chronic Aortic Dissection . (GALLANT Study)

Participants needed: 204
Trial details
Age: 18-80Biological sex: AllType: InterventionalSponsor: Hangzhou Endonom Medtech Co., Ltd.Updated: Apr 30, 2025
Eligibility criteria

Patients aged 18 to 80 years old, no gender limitation; [+5]

Rupture or threatened rupture of aortic dissection; [+15]